Unicycive Therapeutics (UNCY) Assets (2020 - 2026)
Unicycive Therapeutics' (UNCY) quarterly Assets came in at $64.4 million in Q1 2026, up 130.46% YoY from $27.9 million in Q1 2025, and up 31.08% on a QoQ basis from $49.1 million in Q4 2025.
Unicycive Therapeutics (UNCY) Assets (2020 - 2026) Analysis & Trends
Unicycive Therapeutics (UNCY) has 7 years of Assets data on file, last reported at $64.4 million in Q1 2026.
- Quarterly Assets rose 130.46% year-over-year to $64.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.4 million (up 130.46% YoY) and the FY2025 annual result came in at $49.1 million, up 55.16% from the prior year.
- Assets climbed to $64.4 million in Q1 2026, from $49.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $64.4 million in Q1 2026 to a low of $2.8 million in Q4 2022.
- A 5-year average of $30.3 million and a median of $27.9 million in 2025 frame the typical range for Assets.
- The widest YoY moves for Assets: up 1303.72% in 2022, down 84.97% in 2022.
- Tracing UNCY's Assets over 5 years: stood at $2.8 million in 2022, then jumped by 403.58% to $14.2 million in 2023, then surged by 123.16% to $31.7 million in 2024, then surged by 55.16% to $49.1 million in 2025, then soared by 31.08% to $64.4 million in 2026.
- The last three Assets figures came in at $64.4 million (Q1 2026), $49.1 million (Q4 2025), and $50.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Unicycive Therapeutics | 151.01 Mn | 151.01 Mn | - | 72.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.03 Mn |
| Mar 31, 2026 | 64.41 Mn |
| Dec 31, 2025 | 49.14 Mn |
| Sep 30, 2025 | 50.61 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 27.95 Mn |
| Dec 31, 2024 | 31.67 Mn |
| Sep 30, 2024 | 38.57 Mn |
| Jun 30, 2024 | 44.70 Mn |
| Mar 31, 2024 | 52.39 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 19.44 Mn |
| Jun 30, 2023 | 22.88 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | 10.18 Mn |
| Jun 30, 2022 | 12.82 Mn |
| Mar 31, 2022 | 15.76 Mn |
| Dec 31, 2021 | 18.74 Mn |
| Sep 30, 2021 | 19.78 Mn |